ATR
APTARGROUP, INC.
NYSE · Healthcare · Medical - Instruments & Supplies · US
$146.74
+3.11%Year over year
Reported trailing growth
- Revenue
- +9.0%
- EBITDA
- -13.1%
- EBIT
- -7.3%
- EPS
- -34.5%
- Free cash flow
- -3.8%
- Operating cash flow
- +1.6%
Forward estimates
Based on analyst estimates
- Revenue
- +2.3%
- EBITDA
- +20.7%
- EPS
- +46.2%
Three-year CAGR
- Revenue
- +4.4%
- EBITDA
- +10.9%
- EBIT
- +10.5%
- Net income
- +18.0%
- EPS
- +17.7%
- Free cash flow
- +22.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026